Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 79.32

-1.1%

Dec 16 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2270)	2/25/2008 2:21:34 PM
From: Jibacoa	Read Replies (1) of 3722

After trading down for 2nd day on a roll SQNM is trying to find support at the $7 level.<g> bigcharts.marketwatch.com Last week it reported record quarterly revenues for the 4th Q of $11.1M, which was an increase of 41% from the results in 2006. The revenues for the full Yr. were also 44% better But the gross margins were somewhat lower & SQNM was not able to trim its losses in the last 2 Qs. As of Dec 31,SQNM reportedly had assets of $76.1M vs. $39.9M in 2006, with cash & equivalents in 2007 around $53.1M. SQNM expects that this year will be even better, as it will continue building its genetic analysis business & continue the development of its molecular diagnostic programs with its noninvasive prenatal diagnostic franchise. It said that it is also developing its licensed opti-nanopore technology, which they believe it has the potential to deliver a sub-$1,000 human genome analysis, & could "revolutionize" healthcare. <g> As previously mentioned, the "analysts" have a target around $13 to $15 for SQNM, but I continue to wait to see if the stock can find support at the $7 level, which is now close to the 200 day Avg. line.<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next